NP Life Sciences Health Industry Group Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -46.3% | -46.3% | -43.5% |
| FY2020 | -126.2% | -126.2% | -110.5% |
| FY2021 | -172.1% | -172.1% | -171.0% |
| FY2022 | -97.6% | -97.6% | -14.8% |
| FY2023 | -17.9% | -17.9% | -3.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -46.3% | -46.3% | -43.5% |
| FY2020 | -126.2% | -126.2% | -110.5% |
| FY2021 | -172.1% | -172.1% | -171.0% |
| FY2022 | -97.6% | -97.6% | -14.8% |
| FY2023 | -17.9% | -17.9% | -3.8% |